Healthtech incubators and accelerators have proven to be a crucial force for the transformation of global healthcare systems, providing innovators with much needed guidance, connections and early-stage capital.
A panel of leading digital health investors, accelerators and incubators discuss the existing and emergent opportunities and challenges along the commercialisation journey, and where and how key stakeholders should support early stage healthtech start-ups and SMEs.
What will be covered?
- The value incubators and accelerators offer to health-tech start-ups beyond capital - connections, guidance and commercial pathways.
- Where are the existing and emergent opportunities and challenges along the commercialisation journey?
- Where and how should commercial should support early stage healthtech start-ups and SMEs?
Ben Maruthappu, CEO, Cera Care and Co-Founder, NHS Innovation Accelerator
Julia Hagen, Director Politics and Regulatory, Health Innovation Hub
Julia Belaya, Global Head of Business Development for Health, Plug and Play Tech Center
Sophie Park, Chief Strategist, Bayer G4A Digital Health PartnershipsJulia Hagen, Director Politics and Regulatory, Health Innovation Hub
Moderator: Jan-Philipp Beck, CEO, EIT Health
